Biosimilar medicines will be a driver for sustainability in healthcare across Europe

October 30, 2014 7:49 AM

The European Biosimilars Group – a sector group of the EGA, together with the Polish Generic Medicines Association (PZPPF) organised a multi-stakeholder event in Warsaw gathering patient and hospital representatives, health economists, prescribers, industry delegates and research institutes to discuss the challenges and opportunities offered by biosimilar medicines.

Biosimilar medicines play an important role in Poland by offering cost-effective equivalent treatments, contributing to the reliable supply of medicines while preserving healthcare budgets.

According to the GfK study, a sustainable national policy framework for biosimilar medicines should include: unbiased education and information to stakeholders; incentivisation of early use combined with sustainable pricing; collecting evidence about real world experience; and transparent procurement that does not delay time to market. The Polish Association underlined the findings of the GfK study and called for a multi-stakeholder approach to create a sustainable biosimilar medicines market from the perspective of patients, prescribers, payers and industry. The full GfK report can be found here.

EGA Director General, Adrian van den Hoven, said that “as originator biological medicines with billions of euros of sales in Europe come off patent over the next few years, biosimilar medicines will be a driver of sustainability in healthcare in Poland and across Europe by stimulating competition and increasing access for patients”.

Source: EGA press release

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!